Large-scale testing (Phase 3)Looking for participantsNCT06241599
What this trial is testing
A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
Who this might be right for
Recurrent or Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 300